XM does not provide services to residents of the United States of America.
E
E

Eversource


News

BofA sees demand growth to drive investor interest in utilities

BUZZ-BofA sees demand growth to drive investor interest in utilities ** BofA Global Research expects utilities sector to perform well through the remainder of the year ** Brokerage points to rate cuts prospects, the defensive bias of the market in the second half of the year and likely positive business updates around the time of Q3 earnings report
A
E
E

U.S. Centerspace, Neurocrine Biosciences, 1-800-Flowers.com

U.S. RESEARCH ROUNDUP-Centerspace, Neurocrine Biosciences, 1-800-Flowers.com Aug 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Centerspace, Neurocrine Biosciences and Veeva Systems, on Thursday. HIGHLIGHTS * Air Products APD.N : Berenberg raises target price to $275 from $240 * Centerspace CSR.N : Raymond James raises target price to $82 from $75 * Neurocrine Biosciences Inc NBIX.O : Piper Sandler raises to over
A
G
M
N
N
S
A
D
E
E
A
E
P

Eversource Announces New Vice President Of Investor Relations

BRIEF-Eversource Announces New Vice President Of Investor Relations Aug 22 (Reuters) - Eversource Energy ES.N : EVERSOURCE ANNOUNCES NEW VICE PRESIDENT OF INVESTOR RELATIONS Source text for Eikon: ID:nBwFHMC5a Further company coverage: ES.N
E

Scotiabank raises PTs on US utility firms

BUZZ-Scotiabank raises PTs on US utility firms ** Scotiabank raises price targets on several U.S. utility firms as it expects the sector to benefit from a "combination of bullish considerations" ** The PT changes reflect factors like "falling interest rates, a dovish tilt from global central banks, rapidly accelerating load growth outlooks, rising
A
D
E

S&P 500 top and bottom performing stocks at about 12:10 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:10 p.m. EDT S&P 500 .SPX Top Performers Percent Change Ulta Beauty Inc ULTA.OQ +11.9% United Airlines Holdings Inc UAL.OQ +7.2% Cisco Systems Inc CSCO.OQ +7.2% Align Technology Inc ALGN.OQ +7.0% Albemarle Corp ALB.N +6.7% Bottom Performers Percent Change Fair Isaac Corp FICO.N -2.6% CBOE G
A
C
U
U
U
A
M
C
E

Orsted books new losses, flags delay at US offshore wind project

UPDATE 5-Orsted books new losses, flags delay at US offshore wind project Q2 EBITDA up 59%, beats expectations Books impairments of U.S. project delay Keeps full-year profit forecast, says will lower investments Shares end down 7% Adds details on site of soil contamination, background on U.S. offshore wind By Jacob Gronholt-Pedersen COPENHAGEN, Aug 15 (Reuters) - Renewable energy group Orsted ORSTED.CO booked 3.9 billion Danish crowns ($575 million) in impairment losses in the second quarter, du
E

U.S. Agenus, Guardant Health, Zoetis

U.S. RESEARCH ROUNDUP-Agenus, Guardant Health, Zoetis Aug 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agenus, Guardant Health and Zoetis, on Wednesday. HIGHLIGHTS * Agenus Inc AGEN.O : B. Riley cuts target price to $18 from $42 * Clorox CLX.N : Jefferies raises target price to $151 from $148 * Guardant Health Inc GH.O : Raymond James raises target price to $36 from $28 * Starbucks SBUX.O : Stifel raises to buy
A
C
D
E
I
E
A
A
C
E

US corporate bond market issuance set to slow amid market volatility

US corporate bond market issuance set to slow amid market volatility By Matt Tracy and Davide Barbuscia Aug 6 (Reuters) - Some corporate bond issuers are expected to delay sales this week, after market volatility caused investors to trim corporate bond holdings in favor of safer U.S. Treasuries, according to bond market participants. Weaker-than-expected employment and manufacturing growth data last week have stoked recession fears, hitting stocks and causing investors to seek safety in U.S.
E

Eversource Q2 EPS USD 0.95 Vs. IBES Estimate USD 0.96

BRIEF-Eversource Q2 EPS USD 0.95 Vs. IBES Estimate USD 0.96 Jul 31 (Reuters) - Eversource Q2 net income USD 335.3 million vs. IBES estimate USD 344.8 million.
E

BOJ hikes with Fed ahead, Big Tech flubs

MORNING BID AMERICAS-BOJ hikes with Fed ahead, Big Tech flubs A look at the day ahead in U.S. and global markets from Mike Dolan By any standards of an already busy year, markets are digesting an awful lot of information in a very short space of time - with a Bank of Japan interest rate rise and Microsoft earnings disappointment the latest servings on the final day of July.
B
C
E
G
G
H
M
M
N
Q
U
V
W
K
L
G
J
U
U
U
F
I
P
B
E

U.S. Edwards Lifesciences, National Bank Holdings, Sage Therapeutics

U.S. RESEARCH ROUNDUP-Edwards Lifesciences, National Bank Holdings, Sage Therapeutics July 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Edwards Lifesciences, National Bank Holdings and Sage Therapeutics, on Thursday. HIGHLIGHTS * Edwards Lifesciences Corp EW.N : JP Morgan cuts to neutral from overweight * National Bank Holdings Corp NBHC.N : Piper Sandler cuts to neutral from overweight * Sage Therapeutics Inc S
A
A
C
C
G
S
C
E
H
I
A
A
E
L

NY governor announces start of construction on Sunrise Wind project

UPDATE 1-NY governor announces start of construction on Sunrise Wind project Adds more details after first paragraph July 17 (Reuters) - New York Governor Kathy Hochul announced the start of construction on Sunrise Wind, a 924-megawatt offshore wind project developed by Oersted ORSTED.CO , the New York State Energy Research and Development Authority (NYSERDA) said on Wednesday.
E
E
P



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.